Towards an ontological theory of substance intolerance and hypersensitivity

Journal of Biomedical Informatics

Volumn 44, Issue 1, 2011, Pages 26-34

  Hogan, William R ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Allergic condition; Allergy; Drug intolerance; Hypersensitivity; Hypersensitivity reaction; Ontology; Realist ontology; Substance intolerance; Translational research

Indexed keywords

ALLERGIC CONDITION; DRUG INTOLERANCE; HYPERSENSITIVITY; HYPERSENSITIVITY REACTION; REALIST ONTOLOGY; SUBSTANCE INTOLERANCE; TRANSLATIONAL RESEARCH;

ALLERGIES; RESEARCH;

ONTOLOGY;

IMMUNOGLOBULIN E;

ALLERGY; ARTICLE; DRUG HYPERSENSITIVITY; ELECTROMAGNETIC RADIATION; IMMUNITY; INTOXICATION; MEDICAL RESEARCH; MEDICINE; PATHOPHYSIOLOGY; PATIENT CARE; PRIORITY JOURNAL; SEMANTICS; TAXONOMY;

COMPUTATIONAL BIOLOGY; DATABASE MANAGEMENT SYSTEMS; DRUG HYPERSENSITIVITY; FOOD; HUMANS; MEDICAL INFORMATICS; PHARMACEUTICAL PREPARATIONS; VOCABULARY, CONTROLLED;

EID: 79952020322     PISSN: 15320464     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbi.2010.02.003     Document Type: Article

References (29)

1. Saxon A., Diaz-Sanchez D., Zhang K. The allergic response in host defense. Clinical immunology: principles and practice 2001, Mosby, London. 2nd ed. R. Rich, T. Fleisher, W. Shearer, B. Kotzin, H. Schroeder (Eds.).
2. Cowie C.C., Rust K.F., Ford E.S., Eberhardt M.S., Byrd-Holt D.D., Li C., et al. Full accounting of diabetes and pre-diabetes in the US population in 1988-1994 and 2005-2006. Diabetes Care 2009, 32(2):287-294.
3. Gomes E.R., Demoly P. Epidemiology of hypersensitivity drug reactions. Curr Opin Allergy Clin Immunol 2005, 5(4):309-316.
4. Ceusters W., Capolupo M., DeMoor G., Devlies J. Introducing realist ontology for the representation of adverse events. Proceedings of FOIS 2008, IOS Press.
5. Bates B., Hoekelman R. Interviewing and the health history. A guide to physical examination 1983, JB Lippincott Company, Philadelphia. 3rd ed. B. Bates (Ed.).
6. Macy E., Mellon M.H., Schatz M., Patterson R. Drug allergy. Manual of allergy and immunology 2002, Lippincott Williams & Wilkins, Philadelphia. 4th ed. D.C. Adelman, T.B. Casale, J. Corren (Eds.).
7. Zimmerman C.R., Chaffee B.W., Lazarou J., Gingrich C.A., Russell C.L., Galbraith M., et al. Maintaining the enterprisewide continuity and interoperability of patient allergy data. Am J Health Syst Pharm 2009, 66(7):671-679.
8. Lutomski D.M., Lafollette J.A., Biaglow M.A., Haglund L.A. Antibiotic allergies in the medical record: effect on drug selection and assessment of validity. Pharmacotherapy 2008, 28(11):1348-1353.
9. Brockow K., Romano A., Aberer W., Bircher A.J., Barbaud A., Bonadonna P., et al. Skin testing in patients with hypersensitivity reactions to iodinated contrast media-a European multicenter study. Allergy 2009, 64(2):234-241.
10. Lasser E.C. Nonionic iodinated contrast media reactions. AJR Am J Roentgenol 2009, 192(2):W80. [author reply W1].
11. Corneliu H., Bousquet C., Louet A.L.-L., Degoulet P., Jaulent M.-C. Building an ontology of adverse drug reactions for automated signal generation in pharmacovigilance. Comput Biol Med 2006, 36(7):748-767.
12. Bousquet C., Lagier G., Lillo-Le Louet A., Le Beller C., Venot A., Jaulent M.C. Appraisal of the MedDRA conceptual structure for describing and grouping adverse drug reactions. Drug Saf 2005, 28(1):19-34.
13. Brown E.G. Methods and pitfalls in searching drug safety databases utilising the Medical Dictionary for Regulatory Activities (MedDRA). Drug Saf 2003, 26(3):145-158.
14. Merrill G.H. The MedDRA paradox. AMIA Annu Symp Proc 2008, 470-474.
15. Yates A., deShazo R. Drug allergies and hypersensitivity. Clinical immunology: principles and practice 2001, Mosby, London. 2nd ed. R. Rich, T. Fleisher, W. Shearer, B. Kotzin, H. Schroeder (Eds.).
16. Chung W.H., Hung S.I., Chen Y.T. Human leukocyte antigens and drug hypersensitivity. Curr Opin Allergy Clin Immunol 2007, 7(4):317-323.
17. Scheuermann RH, Ceusters W, Smith B. Toward an ontological treatment of disease and diagnosis. AMIA Summit Transl Bioinform; 2009.
18. Ontology for General Medical Science. 2009 [cited 2009 11/24]; Available from: http://code.google.com/p/ogms/.
19. Basic formal ontology version 1.1.1 [cited 2010 Feb 1]; Available from: http://www.ifomis.org/bfo/owl.
20. Issue 30: Physiological processes. 2010 [cited 2010 Feb 1]; Available from: http://code.google.com/p/ogms/issues/detail?id=30.
21. Issue 3: disorder. 2009 [updated 2009; cited 2009 11/24]; Available from: http://code.google.com/p/ogms/issues/detail?id=3.
22. Jansen L. Tendencies and other realizables in medical information sciences. The Monist 2007, 90(4):535-555.
23. Ingelman-Sundberg M. Pharmacogenomic biomarkers for prediction of severe adverse drug reactions. N Engl J Med 2008, 358(6):637-639.
24. Arp R, Smith B. Function, role, and disposition in Basic Formal Ontology. In: Lord P, Shah N, Sansone S-A, Cockerill M, editors. The 11th annual bio-ontologies meeting. Toronto, Canada; 2008. pp. 45-8.
25. Smith B., Ceusters W., Klagges B., Kohler J., Kumar A., Lomax J., et al. Relations in biomedical ontologies. Genome Biol 2005, 6(5):R46.
26. Smith B., Ashburner M., Rosse C., Bard J., Bug W., Ceusters W., et al. The OBO Foundry: coordinated evolution of ontologies to support biomedical data integration. Nat Biotechnol 2007, 25(11):1251-1255.
27. Mungall C., Bada M., Berardini T., Deegan J., Ireland A., Harris M.A., et al. Cross-product extensions of the Gene Ontology. International conference on biomedical ontology 2009, Nature Precedings, Buffalo, NY.
28. Rocca-Serra P., Ruttenberg A., Greenbaum J., Courtot M., Brinkman R., Whetzel P.L., et al. Overcoming the ontology enrichment bottleneck with quick term templates. International conference on biomedical ontology 2009, Nature Precedings, Buffalo, NY.
29. Ceusters W., Smith B. Strategies for referent tracking in electronic health records. J Biomed Inform 2006, 39(3):362-378.